Michael D. Rogers
Keine laufenden Positionen mehr
Profil
Michael D.
Rogers served as Chief Development Officer at Chimerix, Inc. from 2013 to 2016, and at Pharmasset, Inc. from 2007 to 2012.
Prior to that, he was Vice President of the Viral Diseases Division at GSK Plc from 2001 to 2007.
Rogers holds a graduate and doctorate degree from The University of North Carolina at Charlotte.
Ehemalige bekannte Positionen von Michael D. Rogers
| Unternehmen | Position | Ende |
|---|---|---|
| CHIMERIX, INC. | Corporate Officer/Principal | 30.06.2016 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Corporate Officer/Principal | 13.01.2012 |
| GSK PLC | Corporate Officer/Principal | 01.01.2007 |
Ausbildung von Michael D. Rogers
| The University of North Carolina at Charlotte | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| CHIMERIX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
